REGN - BioCryst Clearside Biomedical in pact for diabetic eye disease
2023-11-03 12:59:13 ET
More on BioCryst, Clearside Biomedical, etc.
- BioCryst Pharmaceuticals, Inc. (BCRX) Q3 2023 Earnings Call Transcript
- BioCryst Pharmaceuticals: Q3 Earnings May Not Halt This Stock's Bear Run
- Clearside Biomedical, Inc. (CLSD) Q2 2023 Earnings Call Transcript
- BioCryst Pharmaceuticals Non-GAAP EPS of -$0.19 in-line, revenue of $86.74M beats by $0.68M
- BioCryst Pharmaceuticals Q3 2023 Earnings Preview
For further details see:
BioCryst, Clearside Biomedical in pact for diabetic eye disease